Cornelia Adeola
Research Subjects
Cornelia Adeola has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Dorin Jelaga
Department of Mental Health, Medical Psychology and Psychotherapy “Alexandru Nacu”, and Mental Health Laboratory Nicolae Testemitanu State University of Medicine and Pharmacy Chisinau Republic of Moldova
3 shared publications - Mihaela Belous
Department of Mental Health, Medical Psychology and Psychotherapy “Alexandru Nacu”, and Mental Health Laboratory Nicolae Testemitanu State University of Medicine and Pharmacy Chisinau Republic of Moldova
3 shared publications - Radislav Cosulean
Mental Health Laboratory,“Nicolae Testemițanu” State University of Medicine and Pharmacy, Chișinău, Republic of Moldova
3 shared publications - Alina Bologan2 shared publications
- Andrei Esanu
Universitatea de Medicină și Farmacie Nicolae Testemițanu din Chișinău
2 shared publications - Igor Nastas
Nicolae Testemitanu State University of Medicine and Pharmacy
2 shared publications
Latest Publications
- 11 August 2026
- Published by Bentham Science Publishers Ltd. in Current Psychiatry Research and Reviews
- Vol. 22, 1-18
Telemedicine in the Management of Borderline Personality Disorder and Suicide Risk: A Scoping Review
Introduction/Objective: People with borderline personality disorder have high rates of self-harm and suicide attempts and often present in crisis, yet many cannot access consistent inperson care. Telemedicine may expand timely, less-stigmatized treatment. To map and synthesize the available evidence on the effectiveness, safety, acceptability, and implementation characteristics of telemedicine interventions for adults with borderline personality disorder and suicide risk Methods: We conducted a scoping review in accordance with the PRISMA Extension for Scoping Reviews (PRISMA-ScR). We searched MEDLINE, Embase, PsycINFO, Web of Science, Cochrane Library, and Scopus from inception to 30 June 2025 using combinations of keywords related to borderline personality disorder, BPD, telemedicine, telepsychiatry, telepsychotherapy, digital mental health, suicide, suicidal ideation, self-harm, and non-suicidal self-injury. An updated search was conducted from 1 July 2025 to 1 May 2026, using the same databases and search strategy, to identify newly published eligible studies before resubmission. We included studies on adults with diagnosed or probable borderline personality disorder that evaluated clinician-led, cliniciansupported, or adjunctive digital/telephone interventions delivered via video, telephone, secure messaging, mobile applications, web-based psychoeducation, internet-based self-management tools, or blended digital formats, and reported outcomes on suicidality, non-suicidal self-injury, crisis service use, treatment engagement, or functioning. A total of 19 studies met the inclusion criteria. The updated search did not identify additional studies meeting the eligibility criteria. Methodological quality and study limitations were examined using design-appropriate appraisal tools. Results: Across the included studies, clinician-led telemedicine interventions showed promising but heterogeneous findings for suicidal ideation, non-suicidal self-injury, treatment engagement, and crisis-related outcomes. Several studies reported reductions in suicidal ideation or self-harm, while others showed comparable outcomes to in-person or usual care. Because numerical effect estimates were available only for a subset of studies and outcome measures varied substantially, the findings should be interpreted cautiously. Therapeutic alliance, adherence and satisfaction were generally acceptable and, in some comparative studies, broadly comparable to face-to-face care when core treatment components were preserved, and between-session coaching was available within steppedcare pathways with explicit safety procedures. Discussion: These findings indicate that telemedicine can support core components of borderline personality disorder care, including skills training, structured crisis follow-up and between-session support, when delivered within structured, safety-focused pathways with explicit crisismanagement protocols. However, the certainty of the evidence is limited by heterogeneous study designs, small samples, short follow-up and inconsistent outcome reporting, so telemedicine is best regarded as a promising complement to, rather than a replacement for, in-person care. Conclusion: Telemedicine may represent a feasible and promising component of care for adults with borderline personality disorder and elevated suicide risk when implemented within structured, safetyfocused pathways. Its clinical relevance depends on explicit crisis-management protocols, routine verification of patient location, predefined emergency procedures, and coordination with local services when acute risk escalates. Larger, longer-term trials with standardized self-harm outcomes and explicit attention to digital equity, clinician workload, and cross-context applicability are needed.
- 11 August 2026
- Published by Bentham Science Publishers Ltd. in Current Psychiatry Research and Reviews
- Vol. 22, 1-18
Telemedicine in the Management of Borderline Personality Disorder and Suicide Risk: A Scoping Review
Introduction/Objective: People with borderline personality disorder have high rates of self-harm and suicide attempts and often present in crisis, yet many cannot access consistent inperson care. Telemedicine may expand timely, less-stigmatized treatment. To map and synthesize the available evidence on the effectiveness, safety, acceptability, and implementation characteristics of telemedicine interventions for adults with borderline personality disorder and suicide risk Methods: We conducted a scoping review in accordance with the PRISMA Extension for Scoping Reviews (PRISMA-ScR). We searched MEDLINE, Embase, PsycINFO, Web of Science, Cochrane Library, and Scopus from inception to 30 June 2025 using combinations of keywords related to borderline personality disorder, BPD, telemedicine, telepsychiatry, telepsychotherapy, digital mental health, suicide, suicidal ideation, self-harm, and non-suicidal self-injury. An updated search was conducted from 1 July 2025 to 1 May 2026, using the same databases and search strategy, to identify newly published eligible studies before resubmission. We included studies on adults with diagnosed or probable borderline personality disorder that evaluated clinician-led, cliniciansupported, or adjunctive digital/telephone interventions delivered via video, telephone, secure messaging, mobile applications, web-based psychoeducation, internet-based self-management tools, or blended digital formats, and reported outcomes on suicidality, non-suicidal self-injury, crisis service use, treatment engagement, or functioning. A total of 19 studies met the inclusion criteria. The updated search did not identify additional studies meeting the eligibility criteria. Methodological quality and study limitations were examined using design-appropriate appraisal tools. Results: Across the included studies, clinician-led telemedicine interventions showed promising but heterogeneous findings for suicidal ideation, non-suicidal self-injury, treatment engagement, and crisis-related outcomes. Several studies reported reductions in suicidal ideation or self-harm, while others showed comparable outcomes to in-person or usual care. Because numerical effect estimates were available only for a subset of studies and outcome measures varied substantially, the findings should be interpreted cautiously. Therapeutic alliance, adherence and satisfaction were generally acceptable and, in some comparative studies, broadly comparable to face-to-face care when core treatment components were preserved, and between-session coaching was available within steppedcare pathways with explicit safety procedures. Discussion: These findings indicate that telemedicine can support core components of borderline personality disorder care, including skills training, structured crisis follow-up and between-session support, when delivered within structured, safety-focused pathways with explicit crisismanagement protocols. However, the certainty of the evidence is limited by heterogeneous study designs, small samples, short follow-up and inconsistent outcome reporting, so telemedicine is best regarded as a promising complement to, rather than a replacement for, in-person care. Conclusion: Telemedicine may represent a feasible and promising component of care for adults with borderline personality disorder and elevated suicide risk when implemented within structured, safetyfocused pathways. Its clinical relevance depends on explicit crisis-management protocols, routine verification of patient location, predefined emergency procedures, and coordination with local services when acute risk escalates. Larger, longer-term trials with standardized self-harm outcomes and explicit attention to digital equity, clinician workload, and cross-context applicability are needed.
- 1 December 2025
- Published by Periodic Publication Moldovan Journal of Health Sciences in Moldovan Journal of Health Sciences
- Vol. 12 (4) , 42-49
Prevalence and severity of depression, anxiety, and cognitive impairment in acute ischemic stroke patients: a cross-sectional study
Introduction. Post-stroke depression (PSD) and anxiety are common neuropsychiatric sequelae of stroke, occurring in roughly one-third of survivors. Cognitive impairment is also frequently observed, affecting up to half of stroke patients. These conditions adversely impact rehabilitation and quality of life. This study aimed to determine the prevalence and severity of depression, anxiety, and cognitive deficits in patients with acute ischemic stroke. Material and methods. We conducted an observational study involving 99 patients with acute ischemic stroke, assessed within approximately two weeks of symptom onset, who were admitted to a tertiary care unit. Depression and anxiety were assessed using the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) scales, supplemented by the clinician-rated Hamilton Depression (HAM-D) and Anxiety (HAM-A) scales. Cognitive status was evaluated with the Mini-Mental State Examination (MMSE). Descriptive statistics (proportions, means ± SD) were used to summarize the prevalence and severity of each condition. Results. The cohort had a mean age of 64.8 ± 8.1 years and was 63.5% male. Vascular risk factors were prevalent, with 88% of patients having hypertension and 33% having diabetes. Based on patient-reported measures, 16% of patients exhibited moderate depressive symptoms (PHQ-9 ≥10), while 42% reported moderate to severe anxiety (GAD-7 ≥10). Clinicianadministered assessments identified 35% of patients with moderate to severe depression (HAM-D ≥17) and 35% with clinically significant anxiety (HAM-A ≥18). The vast majority of patients (~92%) reported at least mild depressive symptoms, although only 0-1% met the criteria for severe depression. Conclusions. Depression, anxiety, and cognitive deficits are highly prevalent in the acute phase of ischemic stroke, with approximately one in three patients experiencing clinically significant depression or anxiety and one in four exhibiting cognitive impairment. These findings underscore the importance of early neuropsychological assessment and intervention as part of acute stroke care to improve rehabilitation outcome
- 1 December 2025
- Published by Periodic Publication Moldovan Journal of Health Sciences in Moldovan Journal of Health Sciences
- Vol. 12 (4) , 42-49
Prevalence and severity of depression, anxiety, and cognitive impairment in acute ischemic stroke patients: a cross-sectional study
Introduction. Post-stroke depression (PSD) and anxiety are common neuropsychiatric sequelae of stroke, occurring in roughly one-third of survivors. Cognitive impairment is also frequently observed, affecting up to half of stroke patients. These conditions adversely impact rehabilitation and quality of life. This study aimed to determine the prevalence and severity of depression, anxiety, and cognitive deficits in patients with acute ischemic stroke. Material and methods. We conducted an observational study involving 99 patients with acute ischemic stroke, assessed within approximately two weeks of symptom onset, who were admitted to a tertiary care unit. Depression and anxiety were assessed using the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) scales, supplemented by the clinician-rated Hamilton Depression (HAM-D) and Anxiety (HAM-A) scales. Cognitive status was evaluated with the Mini-Mental State Examination (MMSE). Descriptive statistics (proportions, means ± SD) were used to summarize the prevalence and severity of each condition. Results. The cohort had a mean age of 64.8 ± 8.1 years and was 63.5% male. Vascular risk factors were prevalent, with 88% of patients having hypertension and 33% having diabetes. Based on patient-reported measures, 16% of patients exhibited moderate depressive symptoms (PHQ-9 ≥10), while 42% reported moderate to severe anxiety (GAD-7 ≥10). Clinicianadministered assessments identified 35% of patients with moderate to severe depression (HAM-D ≥17) and 35% with clinically significant anxiety (HAM-A ≥18). The vast majority of patients (~92%) reported at least mild depressive symptoms, although only 0-1% met the criteria for severe depression. Conclusions. Depression, anxiety, and cognitive deficits are highly prevalent in the acute phase of ischemic stroke, with approximately one in three patients experiencing clinically significant depression or anxiety and one in four exhibiting cognitive impairment. These findings underscore the importance of early neuropsychological assessment and intervention as part of acute stroke care to improve rehabilitation outcome
- 1 September 2025
- Published by Periodic Publication Moldovan Journal of Health Sciences in Moldovan Journal of Health Sciences
- Vol. 12 (3) , 117-121
Identifying core stigmatizing beliefs about depression: results from an item-level statistical approach
Introduction. Stigma surrounding depression continues to be a major barrier to treatment, social inclusion, and recovery. While general attitudes toward mental illness have been widely studied, fewer investigations have focused on the specific beliefs that drive stigma toward individuals with depression in a low- and middle-income country (LMIC) in Eastern European settings, particularly in Moldova. Material and methods. A cross-sectional study was conducted with a sample of 460 participants from Moldova, who completed the Depression Stigma Scale. Each of the nine items reflected a different stigmatizing belief about depression. Descriptive statistics, including mean scores and standard deviations, were calculated for each item. An item-level comparative analysis was performed. Results. The highest stigma scores were recorded for items such as: "I would not employ someone if I knew they had been depressed", "Depression is not a real medical illness", and "Depression is a sign of personal weakness." The lowest scores were observed for beliefs related to dangerousness and avoidance, including "People with depression are dangerous" and "It is best to avoid people with depression so you don't become depressed yourself." These results suggest that stigma in Moldova is predominantly characterized by doubts about the medical legitimacy of depression and concerns over professional roles, rather than fear-based or exclusionary attitudes. Conclusions. Anti-stigma interventions in LMICs, such as Moldova should prioritize improving public understanding of depression as a legitimate health condition and addressing discrimination in professional settings.
- 1 September 2025
- Published by Periodic Publication Moldovan Journal of Health Sciences in Moldovan Journal of Health Sciences
- Vol. 12 (3) , 117-121
Identifying core stigmatizing beliefs about depression: results from an item-level statistical approach
Introduction. Stigma surrounding depression continues to be a major barrier to treatment, social inclusion, and recovery. While general attitudes toward mental illness have been widely studied, fewer investigations have focused on the specific beliefs that drive stigma toward individuals with depression in a low- and middle-income country (LMIC) in Eastern European settings, particularly in Moldova. Material and methods. A cross-sectional study was conducted with a sample of 460 participants from Moldova, who completed the Depression Stigma Scale. Each of the nine items reflected a different stigmatizing belief about depression. Descriptive statistics, including mean scores and standard deviations, were calculated for each item. An item-level comparative analysis was performed. Results. The highest stigma scores were recorded for items such as: "I would not employ someone if I knew they had been depressed", "Depression is not a real medical illness", and "Depression is a sign of personal weakness." The lowest scores were observed for beliefs related to dangerousness and avoidance, including "People with depression are dangerous" and "It is best to avoid people with depression so you don't become depressed yourself." These results suggest that stigma in Moldova is predominantly characterized by doubts about the medical legitimacy of depression and concerns over professional roles, rather than fear-based or exclusionary attitudes. Conclusions. Anti-stigma interventions in LMICs, such as Moldova should prioritize improving public understanding of depression as a legitimate health condition and addressing discrimination in professional settings.